Back to Search Results
David Hirsh
Schedule an appointment (614) 761-7000
Insurances We Accept
I am a neuro-ophthalmologist, trained in neurology and ophthalmology residencies, as well as two years in a neuro-ophthalmology fellowship.

Neuro-ophthalmology is a specialty in the borderland between neurology and ophthalmology. Ophthalmologists may have more expertise in vision exams than diseases, while neurologists may have more expertise in diseases than vision examination. So, there is a need for physicians who have expertise in both.

Being an ophthalmologist, I know the ophthalmic diseases which can masquerade as neurologic vision loss, and vice versa. Common conditions that I evaluate include double vision, optic nerve disease, multiple sclerosis-related vision problems and stroke-induced vision loss.

I immensely enjoy the opportunity that being at Ohio State gives me to teach medical students, neurologists and ophthalmologists in training. I also enjoy the stimulating, productive interactions that come from having subspecialty ophthalmologists right here.

I’m very focused on educating my patients as well. The more patients know and understand about their illness, the less frightening it will be for them.

Highlights

  • Co-director, ophthalmology residents’ neuro-ophthalmology lecture series
  • Lecturer to neurology residents
  • Neuro-ophthalmic lectures for students, technicians and others

Medical Degree

  • M.D.
    Albert Einstein College of Medicine
    6/30/1984

Residencies

  • Ophthalmology
    Henry Ford Health Systems
    7/1/1991 - 6/30/1994
  • Neurology
    Sch. of Med. SUNY at Stony Brook
    7/1/1985 - 6/30/1988
  • Neurology
    Henry Ford Health Systems
    7/1/1990 - 9/30/2001

Specialties and conditions I treat

  • Ophthalmology
  • Ophthalmology
  • Strabismus
  • Diplopia
  • Optic Nerve Diseases
  • Pupil Disorders
  • Hypertensive Retinopathy
  • Neuromyelitis Optica
  • Susac Syndrome
  • Optic Neuritis
  • Miller Fisher Syndrome
  • Kearns-Sayre Syndrome
  • Ophthalmoplegia, Chronic Progressive External
  • Ophthalmoplegia
  • Oculomotor Nerve Injuries
  • Optic Nerve Injuries
  • Supranuclear Palsy, Progressive
  • Retinal Artery Occlusion
  • Scotoma
  • Optic Nerve Tumors
  • Iridocyclitis
  • Iritis
  • Conjunctivitis, Bacterial
  • Eye Pain
  • Photophobia
  • Low Tension Glaucoma
  • Optic Atrophy
  • Optic Disk Drusen
  • Optic Neuropathy, Ischemic
  • Papilledema
  • Duane Retraction Syndrome
  • Optic Atrophies, Hereditary
  • Amaurosis Fugax
  • Blindness, Cortical
  • Optic Nerve Glioma
  • Wolfram Syndrome
  • Oculomotor Nerve Diseases
  • Anisocoria
  • Horner Syndrome
  • Miosis
  • Mydriasis
  • Tonic Pupil
  • Adie Syndrome
  • Nystagmus, Congenital
  • Nystagmus, Pathologic
  • Ophthalmoplegic Migraine
  • Opsoclonus-Myoclonus Syndrome
  • Esotropia
  • Exotropia
  • Tolosa-Hunt Syndrome
  • Optic Atrophy, Autosomal Dominant
  • Optic Atrophy, Hereditary, Leber
  • Vision Disorders
  • Ocular Motility Disorders

My videos

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowships

  • Neuro-Ophthalmology
    Henry Ford Health Systems
    7/1/1989 - 6/30/1990
  • Neuro-Ophthalmology
    University of Michigan Hospitals
    7/1/1988 - 6/30/1989

Board Certification

American Board of Ophthalmology
10/1/1995

My Department

Ophthalmology

Industry Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/25/2016, Dr. Hirsh has reported no financial relationships with medical device, research and/or drug companies.